Psychiatr. praxi 2018; 19(2): 48-51 | DOI: 10.36290/psy.2018.012

Neuropsychiatric symptoms in Parkinson’s disease in older age

MUDr. Vanda Franková, MUDr. Ivana Horská
Psychiatrická nemocnice v Dobřanech

Neuropsychiatric symptoms are very common in Parkinson’s disease, especially in its later stage. They are often under-recognizedand poorly managed. Early intervention may prevent progression of symptoms and development of life-threatening behaviour.Clinicians are advised to routinely screen for psychiatric symptoms in the office and modify Parkinson’s disease treatment accordinglyor consider the addition of psychopharmacotherapy: rivastigmine in dementia and psychosis, SSRI or other antidepressivemedication in anxiety and depression, an atypical antipsychotic (quetiapine, clozapine) in low doses in psychosis or aggressivebehaviour if necessary. Non-pharmacological approaches are important. Case reports are presented.

Keywords: Parkinson’s disease, neuropsychiatric symptoms, management

Published: June 26, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Franková V, Horská I. Neuropsychiatric symptoms in Parkinson’s disease in older age. Psychiatr. praxi. 2018;19(2):48-51. doi: 10.36290/psy.2018.012.
Download citation

References

  1. Roth J, Sekyrová M, Růžička E, et al. Parkinsonova nemoc. 4. rozšířené vydání. Praha: Maxdorf 2009.
  2. Ulmanová O, Růžička E. Parkinsonova nemoc - základy terapie a diferenciální diagnostiky. Psychiat pro praxi 2007; 2: 60-62.
  3. Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord. 2009; 24(15): 2175-2186. Go to original source... Go to PubMed...
  4. Ebmeier KP, O'Brien JT, Taylor J-P, eds. Psychiatry of Parkinson's disease. Basel:Karger 2012. Go to original source...
  5. Státní ústav pro kontrolu léčiv (online). Dostupné z: http://www.sukl.cz/modules/medication/search.php.
  6. Ferreira JJ, Katzenschlager R, Bloem BR, Bonucelli U, Burn D, Deuschl G, et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. European Journal of Neurology 2013;20:5-15. Go to original source...
  7. Weintraub D, Burn DJ. Parkinson's disease: The Quinessential Neuropsychiatric Disorder. Mov Disord. 2011; 26(6): 1022-1031. Go to original source... Go to PubMed...
  8. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts Ch, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22(12):1689-1707. Go to original source... Go to PubMed...
  9. Friedman JH. Parkinson's disease psychosis: Update. Behavioural Neurology 2013; 27: 469-477. Go to original source...
  10. Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, et al. Diagnostic criteria for psychosis in Parkinson's disease: Report of an NIND, NIMH work group. Mov Disord 2007; 22(8):1061-1068. Go to original source... Go to PubMed...
  11. The IPA Complete Guides to Behavioral and Psychological Symptoms of Dementia - Specialist Guide. International Psychogeriatric Association (online). Dostupné z: https://www.ipa-online.org/members/publications/bpsd
  12. Sorbi S, Hort J, Erkinjuntti et al. EFNS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 2012; 19(9): 1159-1179. Go to original source...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.